2019 Low-Grade Glioma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Low-Grade Glioma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Low-Grade Glioma. It presents in-depth analysis of Low-Grade Glioma clinical trials across markets and companies. The research work is for providing complete understanding into trends in Low-Grade Glioma.
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Low-Grade Glioma clinical trials by-
The research work is prepared through extensive and continuous research on Low-Grade Glioma trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Low-Grade Glioma clinical trials by-
- Current Trial Status
- Type of the trial
- Sponsor Type
- Enrollment Trends
- Region
- Countries
- Trial Phase
The research work is prepared through extensive and continuous research on Low-Grade Glioma trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
- All major trials from 2010 to 2019 and planned trials are included in the report scope.
- Drug candidates currently being researched for administering Low-Grade Glioma patients are identified
- The report includes panorama of Low-Grade Glioma clinical trials across the globe
- Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
- Companies and universities focusing on Low-Grade Glioma clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
- Average Enrollment number, insights into enrollment trends, company wise enrollment are included
- Both interventional and observational studies are analyzed
- News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Low-Grade Glioma Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Low-Grade Glioma Clinical Trials by Region
2.2.2 Average Enrollment of Low-Grade Glioma Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Low-Grade Glioma Treatment, 2019
3. REGION WISE LOW-GRADE GLIOMA CLINICAL TRIALS
3.1 Asia Pacific Low-Grade Glioma Clinical Trials by Country
3.2 Europe Low-Grade Glioma Clinical Trials by Country
3.3 North America Low-Grade Glioma Clinical Trials by Country
3.4 Middle East and Africa Low-Grade Glioma Clinical Trials by Country
3.5 South and Central America Low-Grade Glioma Clinical Trials by Country
4. LOW-GRADE GLIOMA CLINICAL TRIAL TRENDS
4.1 Start Year wise Low-Grade Glioma Clinical Trials
4.2 Phase wise Low-Grade Glioma Clinical Trials
4.3 Trial Status wise Low-Grade Glioma Clinical Trials
4.4 Trial Type wise Low-Grade Glioma Clinical Trials
5. LOW-GRADE GLIOMA AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Low-Grade Glioma Trials by Year
5.2 Average Enrollment in Low-Grade Glioma Trials by Phase
5.3 Average Enrollment in Low-Grade Glioma Trials by Status
5.4 Average Enrollment in Low-Grade Glioma Trials by Type of Trial
6. COMPANIES PARTICIPATING IN LOW-GRADE GLIOMA CLINICAL TRIALS
6.1 Low-Grade Glioma Trials by Sponsor Type
6.2 Low-Grade Glioma Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Low-Grade Glioma Trials- Phase
7.2 Low-Grade Glioma Trials- Phase
7.3 Low-Grade Glioma Trials- Phase
7.4 Low-Grade Glioma Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Low-Grade Glioma Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Low-Grade Glioma Clinical Trials by Region
2.2.2 Average Enrollment of Low-Grade Glioma Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Low-Grade Glioma Treatment, 2019
3. REGION WISE LOW-GRADE GLIOMA CLINICAL TRIALS
3.1 Asia Pacific Low-Grade Glioma Clinical Trials by Country
3.2 Europe Low-Grade Glioma Clinical Trials by Country
3.3 North America Low-Grade Glioma Clinical Trials by Country
3.4 Middle East and Africa Low-Grade Glioma Clinical Trials by Country
3.5 South and Central America Low-Grade Glioma Clinical Trials by Country
4. LOW-GRADE GLIOMA CLINICAL TRIAL TRENDS
4.1 Start Year wise Low-Grade Glioma Clinical Trials
4.2 Phase wise Low-Grade Glioma Clinical Trials
4.3 Trial Status wise Low-Grade Glioma Clinical Trials
4.4 Trial Type wise Low-Grade Glioma Clinical Trials
5. LOW-GRADE GLIOMA AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Low-Grade Glioma Trials by Year
5.2 Average Enrollment in Low-Grade Glioma Trials by Phase
5.3 Average Enrollment in Low-Grade Glioma Trials by Status
5.4 Average Enrollment in Low-Grade Glioma Trials by Type of Trial
6. COMPANIES PARTICIPATING IN LOW-GRADE GLIOMA CLINICAL TRIALS
6.1 Low-Grade Glioma Trials by Sponsor Type
6.2 Low-Grade Glioma Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Low-Grade Glioma Trials- Phase
7.2 Low-Grade Glioma Trials- Phase
7.3 Low-Grade Glioma Trials- Phase
7.4 Low-Grade Glioma Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
LIST OF FIGURES
Figure 1: Low-Grade Glioma Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Figure 5: Europe – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Figure 7: North America – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Figure 9: Low-Grade Glioma Clinical Trials by Phase
Figure 10: Low-Grade Glioma Clinical Trials by Trial Status
Figure 11: Low-Grade Glioma Clinical Trials by Type
Figure 12: Low-Grade Glioma Clinical Trials by Sponsor Type
Figure 13: Low-Grade Glioma Clinical Trials by Leading Sponsors
Figure 14: Low-Grade Glioma Average Enrollment by Phase
Figure 15: Low-Grade Glioma Average Enrollment by Trial Status
Figure 16: Low-Grade Glioma Average Enrollment by Type
Figure 17: Low-Grade Glioma- Average Enrolment by Type of Sponsors
Figure 18: Low-Grade Glioma- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
Figure 1: Low-Grade Glioma Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Figure 5: Europe – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Figure 7: North America – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Figure 9: Low-Grade Glioma Clinical Trials by Phase
Figure 10: Low-Grade Glioma Clinical Trials by Trial Status
Figure 11: Low-Grade Glioma Clinical Trials by Type
Figure 12: Low-Grade Glioma Clinical Trials by Sponsor Type
Figure 13: Low-Grade Glioma Clinical Trials by Leading Sponsors
Figure 14: Low-Grade Glioma Average Enrollment by Phase
Figure 15: Low-Grade Glioma Average Enrollment by Trial Status
Figure 16: Low-Grade Glioma Average Enrollment by Type
Figure 17: Low-Grade Glioma- Average Enrolment by Type of Sponsors
Figure 18: Low-Grade Glioma- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
LIST OF TABLES
Table 1: Low-Grade Glioma Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Table 5: Europe – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Table 7: North America – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Low-Grade Glioma Average Enrollment by Phase
Table 15: Low-Grade Glioma Average Enrollment by Trial Status
Table 16: Low-Grade Glioma Average Enrollment by Type
Table 17: Low-Grade Glioma- Average Enrolment by Type of Sponsors
Table 18: Low-Grade Glioma- Enrolment by Leading Sponsors
Table 1: Low-Grade Glioma Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Table 5: Europe – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Table 7: North America – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Low-Grade Glioma Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Low-Grade Glioma Average Enrollment by Phase
Table 15: Low-Grade Glioma Average Enrollment by Trial Status
Table 16: Low-Grade Glioma Average Enrollment by Type
Table 17: Low-Grade Glioma- Average Enrolment by Type of Sponsors
Table 18: Low-Grade Glioma- Enrolment by Leading Sponsors
